RENAL FUNCTION OF AN EVEROLIMUS BASED THERAPY AFTER CALCINEURIN INHIBITOR WITHDRAWAL IN MAINTENANCE RENAL TRANSPLANT RECIPIENTS ONE YEAR AFTER CONVERSION

被引：0
|
作者：
Reinke, P.
Rath, T.
Budde, K.
Arns, W.
Kramer, S. [1 ]
Vogel, E. -M. [1 ]
Pietruck, F.
Haller, H.
Sommerer, C.
机构：
[1] Novartis Pharmaceut, Numberg, Germany
来源：
TRANSPLANT INTERNATIONAL | 2010年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
0171
引用
收藏
页码：48 / 48
页数：1
相关论文
共 50 条
  • [21] Evaluation of the efficacy and safety of the conversion from a calcineurin inhibitor to an everolimus-based therapy in maintenance renal transplant patients
    Fructuoso, A. Sanchez
    Millan, J. C. Ruiz San
    Calvo, N.
    Rodrigo, E.
    Moreno, M. A.
    Cotorruelo, J.
    Conesa, J.
    Gomez-Alamillo, C.
    Arias, M.
    Barrientos, A.
    [J]. TRANSPLANTATION PROCEEDINGS, 2007, 39 (07) : 2148 - 2150
  • [22] CALCINEURIN INHIBITOR WITHDRAWAL IN THE PRESENCE OF EVEROLIMUS IS FEASIBLE IN MAINTENANCE LIVER TRANSPLANT RECIPIENTS
    Fischer, Lutz
    De Simone, Paolo
    Nevens, Frederik
    Metselaat, Herold J.
    Dumortier, Jerome
    Duvoux, Christophe
    Boudjema, Karim
    Le Treut, Yves Patrice
    Sterneck, Martina R.
    [J]. HEPATOLOGY, 2008, 48 (04) : 566A - 566A
  • [23] Glucose metabolism in renal transplant recipients: Effect of calcineurin inhibitor withdrawal and conversion to sirolimus
    Teutonico, A
    Schena, PF
    Di Paolo, S
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (10): : 3128 - 3135
  • [24] Analysis of Renal Function in Everolimus/Enteric-Coated Mycophenolate Sodium Treated De Novo Renal Transplant Recipients after Calcineurin Inhibitor Withdrawal: The ZEUS Study.
    Budde, K.
    Becker, T.
    Arns, W.
    Sommerer, C.
    Reinke, P.
    Eisenberger, U.
    Fischer, W.
    Kramer, S.
    Pietruck, F.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 259 - 259
  • [25] Calcineurin inhibitor withdrawal in renal transplant recipients: Improvement in renal function and reduction of cardiovascular risk.
    Mazzali, M
    Quadros, KRS
    Santos, RLS
    Alves, G
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 650A - 650A
  • [26] Predictors of improvement in renal function after calcineurin inhibitor withdrawal for post-liver transplant renal dysfunction
    Hong, MKH
    Angus, PW
    Jones, RM
    Vaughan, RB
    Gow, PJ
    [J]. CLINICAL TRANSPLANTATION, 2005, 19 (02) : 193 - 198
  • [27] RENAL FUNCTION IN EVEROLIMUS/ENTERIC-COATED MYCOPHENOLATE SODIUM TREATED DE NOVO LIVING RENAL TRANSPLANT RECIPIENTS AFTER CALCINEURIN INHIBITOR WITHDRAWAL: SUBGROUP ANALYSIS OF THE ZEUS STUDY
    Lehner, F.
    Arns, W.
    Reinke, P.
    Eisenberger, U.
    Paulus, E. -M.
    Scheidl, S.
    Witzke, O.
    Budde, K.
    Sommerer, C.
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 50 - 51
  • [28] Relationship between renal resistance index and renal function in liver transplant recipients after cessation of calcineurin inhibitor
    Eisenberger, Ute
    Sollinger, Daniel
    Stickel, Felix
    Burckhardt, Beat
    Frey, Felix J.
    [J]. CLINICAL TRANSPLANTATION, 2009, 23 (04) : 499 - 504
  • [29] Renal function after steroid withdrawal in liver transplant recipients
    Cibrik, DM
    Post, AB
    Hricik, DE
    [J]. TRANSPLANTATION, 1999, 67 (07) : S202 - S202
  • [30] Mycophenolate Mofetil/Sirolimus Maintenance Therapy after Calcineurin Inhibitor Withdrawal in Renal Transplant Recipients: 2-Year Outcomes of the Spare-the-Nephron (STN) Trial.
    Weir, M.
    Mulgaonkar, S.
    Pearson, T.
    Patel, A.
    Patel, D.
    Shidban, H.
    Scandling, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 200 - 201
12345